Pediatric choroidal neovascularization: Etiology and treatment outcomes with anti-vascular endothelial growth factors

Ratnesh Ranjan1, Romit Salian1, Shishir Verghese1

  • 1Department of Retina and Vitreous services, Aravind Eye Hospital, Coimbatore, India.

Insights

Intravitreal anti-vascular endothelial growth factor (VEGF) injections effectively treat choroidal neovascularization (CNV) in children. This therapy led to significant visual acuity improvement and reduced macular thickness in pediatric patients.

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Pediatric Medicine

Background:

  • Choroidal neovascularization (CNV) can impact vision in pediatric patients.
  • Treatment options for pediatric CNV require evaluation for efficacy and safety.

Purpose of the Study:

  • To determine the etiology and treatment outcomes of pediatric choroidal neovascularization (CNV).
  • To assess the effectiveness of intravitreal anti-vascular endothelial growth factor (VEGF) agents in treating pediatric CNV.

Main Methods:

  • Retrospective, single-center interventional case series.
  • Treatment involved intravitreal injections of anti-VEGF agents in 26 eyes of 23 pediatric patients.
  • Data collected included etiology, visual acuity, and macular thickness.

Main Results:

  • Inflammatory CNV was the most common cause in the pediatric cohort.
  • Intravitreal anti-VEGF therapy resulted in significant improvement in best-corrected visual acuity (BCVA) (logMAR 0.8 to 0.4, p < 0.0001).
  • Mean central macular thickness (CMT) significantly decreased (367.6 µm to 242.5 µm, p < 0.0001) with a mean of two injections per eye.

Conclusions:

  • Intravitreal anti-VEGF therapy is an effective treatment for pediatric choroidal neovascularization.
  • The treatment demonstrated positive outcomes in visual acuity and macular structure in children.
Abstract

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
753
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
889
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
247
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
177
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
981